Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11827LMP | RISANKIZUMAB risankizumab 75 mg/0.83 mL injection, 2 x 0.83 mL syringes (PI, CMI) |
1 | 2 | 2 | $5401.42 | $31.60 | $31.60 |
Available brands | |||||||
Skyrizi
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11858DMP | RISANKIZUMAB risankizumab 75 mg/0.83 mL injection, 2 x 0.83 mL syringes (PI, CMI) |
1 | 2 | 1 | $5401.42 | $31.60 | $31.60 |
Available brands | |||||||
Skyrizi
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
RISANKIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14111QMP | RISANKIZUMAB risankizumab 150 mg/mL injection, 1 mL pen device (PI, CMI) |
1 | 1 | 2 | $5401.42 | $31.60 | $31.60 |
Available brands | |||||||
Skyrizi |
RISANKIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14142HMP | RISANKIZUMAB risankizumab 150 mg/mL injection, 1 mL pen device (PI, CMI) |
1 | 1 | 1 | $5401.42 | $31.60 | $31.60 |
Available brands | |||||||
Skyrizi |
- Legend
- MPMedical Practitioner
-
SO
Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.